asthma%20(pediatric)
ASTHMA (PEDIATRIC)

Asthma is a chronic inflammatory disease of the airways in the lungs of children and adults.
The patient usually complains of shortness of breath, chest tightness and coughing with wheezing.

A diagnosis of asthma in young children is more likely if they have symptom patterns, presence of risk factors for development of asthma and therapeutic response to controller treatment.
Goals of treatment are effective symptom control with minimal or no exacerbations, minimal or no nocturnal and daytime symptoms, no limitations on activities, minimal or no need for reliever treatment, and minimal adverse effects of medication.

Asthma%20(pediatric) Patient Education

Patient Education

  • Includes skills training, symptom monitoring, and a written personal asthma action plan 
  • Aims to actively involve the children, their families and caregivers in managing asthma
  • Education should be provided over several visits
    • Studies have shown that asthma control is improved with the use of written asthma management plan together with careful verbal explanation of the treatment regimen
  • Develop patient/doctor partnership
    • Objective is to give patients the ability to control their asthma with guidance from health care professionals 
  • The patient, parents and caregivers should be able to apply the following objectives
    • Avoid triggers and aggravating factors
    • Take medications accurately and appropriately
    • Understand the difference between “controller” and “reliever” medications
    • Train about correct inhalation technique
    • Monitor asthma control status
    • Recognize signs of worsening asthma and take appropriate action
    • Seek medical help when necessary

Written Asthma Action Plan

  • May help patients and patient's parents/guardian/caregiver recognize and respond appropriately to an asthma attack
  • Should include specific, individualized instructions about medications and medical care access
  • Changes to medications may include the following:
    • Increasing as-needed inhaled low-dose corticosteroid-Formoterol doses
    • The use of an inhaler containing rapid-onset long-acting beta2-agonist with low-dose corticosteroid
    • Other inhaled corticosteroids and inhaled corticosteroid-long-acting beta2-agonist maintenance controlled regimens
    • A short-course oral corticosteroids for patients unresponsive to increased doses of reliever and controller medications, rapid deterioration, PEF or FEV1 <60% of personal best, or a history of sudden severe exacerbations
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Pearl Toh, 26 Nov 2020
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
Audrey Abella, 6 days ago
A pilot telemedicine initiative may be an alternative for facilitating delivery of intravenous iron (IVI) for individuals requiring iron supplementation.